• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Eicosanoids and respiratory viral infection: coordinators of inflammation and potential therapeutic targets

tetano

Editor, Senior Moderator
Mediators Inflamm. 2012;2012:236345. Epub 2012 May 15.
Eicosanoids and respiratory viral infection: coordinators of inflammation and potential therapeutic targets.
McCarthy MK, Weinberg JB.
Source

Department of Microbiology and Immunology, University of Michigan, Ann Arbor, MI 48109, USA.
Abstract

Viruses are frequent causes of respiratory infection, and viral respiratory infections are significant causes of hospitalization, morbidity, and sometimes mortality in a variety of patient populations. Lung inflammation induced by infection with common respiratory pathogens such as influenza and respiratory syncytial virus is accompanied by increased lung production of prostaglandins and leukotrienes, lipid mediators with a wide range of effects on host immune function. Deficiency or pharmacologic inhibition of prostaglandin and leukotriene production often results in a dampened inflammatory response to acute infection with a respiratory virus. These mediators may, therefore, serve as appealing therapeutic targets for disease caused by respiratory viral infection.

PMID:
22665949
[PubMed - in process]
PMCID:
PMC3362132

Free full text

http://www.ncbi.nlm.nih.gov/pubmed/22665949
 
Back
Top Bottom